17 / 21
Parkinsonismen
Literatuurlijst
1.
Abbott S, Videnovic A. Sleep disorders in atypical parkinsonism. Mov Disord Clin Pract (Hoboken) 2014;1:89-96.
2.
Benamer H, Grosset D. Vascular parkinsonism: a clinical review. Eur Neurol 2009;61:11-15.
3.
Bohlhalter S, Kagi G. Parkinsonism: heterogeneity of a common neurological syndrome. Swiss MedWkly 2011;141:w13293.
4.
Broski S, Hunt C, Johnson G, Morreale R, Lowe V, Peller P. Structural and functional imaging in parkinsonian syndromes.
RadioGraphics 2014;34:1273-1292.
5.
Brown R, Lockwood A, Sonawane B. Neurodegenerative diseases: an overview of environmental risk factors. Environ Health
Perspect 2005;113:1250-1256.
6.
Cardoso Vale T, Caramelli P, Cardoso F. Vascular parkinsonism: a series of 17 cases. Arq Neuropsiquiatr 2013;71:757-762.
7.
Colosimo C, Bak T, Bologna M, Berardelli A. Fifty years of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry
2014;85:936-942.
8.
Donker Kaat L, Boon A, Heutink P, van Swieten J. Progressieve supranucleaire verlamming; een bijzondere vorm van
parkinsonisme. Ned Tijdschr Geneeskd 2004;148:519-523.
9.
Fereshtehnejad S, Lokk J. Orthostatic hypotension in patients with Parkinson’s disease and atypical parkinsonism.
Parkinsons Dis 2014;2014:475854.
10. Flabeau O, Meissner W, Tison F. Multiple system atrophy: current and future approaches to management. Ther Adv Neurol
Disord 2010;3:249-263.
11. Golbe L. Progressive supranuclear palsy. Semin Neurol 2014;34:151-159.
12. Hendriks S. Generieke zorgthema Huisartsgeneeskundige zorg. 2014.
www.zorgstandaarden.net/nl/wat-is-een-zeldzame-aandoening/generieke-zorgthemas.
13. Kaindlstorfer C, Granata R, Wenning G. Tremor in multiple system atrophy – a review. Tremor Other Hyperkinet Mov (NY)
2013;3:tre-03-165-4252-1.
14. Perez-Lloret S, Flabeau O, Fernagut P, Pavy-Le Traon A, Rey M, Foubert-Samier A, et al. Current concepts in the treatment of
multiple system atrophy. Mov Dis 2014; DOI: 10.1002/mdc3.12145.
15. Rehman H. Progressive supranuclear palsy. Postgrad Med J 2000;76:333–336.
16. Rehman H. Multiple system atrophy. Postgrad Med J 2001;77:379–382.
17. Roncevic D, Palma J, Martinez J, Goulding N, Norcliffe-Kaufmann L, Kaufmann H. Cerebellar and parkinsonian phenotypes
in multiple system atrophy: similarities, differences and survival. J Neural Transm. 2014;121:507–512.
18. Sato Y, Iwamoto J, Honda Y, Amano N. Vitamin D reduces falls and hip fractures in vascular parkinsonism but not in
Parkinson’s disease. Ther Clin Risk Manag 2013;9:171–176.
19. Stankovic I, Krismer F, Jesic A, Antonini A, Benke T, Brown R, et al. Cognitive impairment in multiple system atrophy: a
position statement by the Neuropsychology Task Force of the MDS multiple system atrophy (MODIMSA) Study Group. Mov
Disord 2014;29:857–867.
20. O’Sullivan S, Massey L, Williams D, Silveira-Moriyama L, Kempster P, Holton J, et al. Clinical outcomes of progressive
supranuclear palsy and multiple system atrophy. Brain 2008;131:1362-1372.
21. Thanvi B, Lo N, Robinson T. Vascular parkinsonism – an important cause of parkinsonism in older people. Age Ageing
2005;34:114-119.
22. Vajda I. Visiedocument Concentratie en organisatie van zorg bij zeldzame aandoeningen. 2015.
www.zorgstandaarden.net/ zza/media/upload/pages/file/Visiedocument/Visiedocument-Concentratie-en-Organisatie-mei-2015.pdf .15